Strategies to increase the resectability of hepatocellular carcinoma

World Journal of Hepatology

Volumn 7, Issue 18, 2015, Pages 2147-2154

  She, Wong Hoi ^a   Chok, Kenneth S H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Associating liver partition and portal vein ligation in staged hepatectomy; Hepatectomy; Hepatocellular carcinoma; Portal vein embolization; Portal vein ligation

Indexed keywords

EID: 84940366942     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i18.2147     Document Type: Review

References (101)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750 DOI: 10.1016/S0140-6736(03)14964-1].
2. Kim do Y, Han KH. Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 2012; 1: 2-14 [PMID: 24159567 DOI: 10.1159/000339016].
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516].
4. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43 [PMID: 19058754 DOI: 10.1016/S1470-2045(08)70284-5].
5. Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 2010; 101: 47-53 [PMID: 19798686 DOI: 10.1002/jso.21415].
6. Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, Ogawa K, Sakamoto S, Ogura Y, Egawa H, Tanaka K, Uemoto S. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007; 13: 1637-1644 [PMID: 18044766 DOI: 10.1002/lt.21281].
7. Tamura S, Sugawara Y, Kokudo N. Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience. Oncology 2011; 81 Suppl 1: 111-115 [PMID: 22212944 DOI: 10.1159/000333270].
8. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004; 10: 440-447 [PMID: 15004774 DOI: 10.1002/lt.20097].
9. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104].
10. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403 [PMID: 11391528 DOI: 10.1053/jhep.2001.24563].
11. Fan ST, Poon RT, Yeung C, Lam CM, Lo CM, Yuen WK, Ng KK, Liu CL, Chan SC. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg 2011; 98: 1292-1300 [PMID: 21656513 DOI: 10.1002/bjs.7583].
12. Poon RT, Fan ST. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 2005; 12: 31-37 [PMID: 15754097 DOI: 10.1007/s00534-004-0945-0].
13. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 2002; 236: 602-611 [PMID: 12409666 DOI: 10.1097/01.SLA.0000033038.38956.5E].
14. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK, Ming Lam C, Ng KK, Ching Chan S. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011; 253: 745-758 [PMID: 21475015 DOI: 10.1097/SLA.0b013e3182111195].
15. Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 2014; 146: 1691-700.e3 [PMID: 24583061 DOI: 10.1053/j. gastro.2014.02.032].
16. Cauchy F, Soubrane O, Belghiti J. Liver resection for HCC: patient's selection and controversial scenarios. Best Pract Res Clin Gastroenterol 2014; 28: 881-896 [PMID: 25260315 DOI: 10.1016/j.bpg.2014.08.013].
17. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999; 16: 459-467 [PMID: 10805544 DOI: 10.1159/000018770].
18. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001; 193: 109-111 [PMID: 11442247 DOI: 10.1016/S1072-7515(01)00909-7].
19. Liu CL, Fan ST, Lo CM, Tung-Ping Poon R, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 2000; 232: 25-31 [PMID: 10862191 DOI: 10.1097/00000658-200007000-00004].
20. Fan ST, Liu CL. Anterior approach for major right hepatic resection. J Hepatobiliary Pancreat Surg 2005; 12: 356-361 [PMID: 16258802 DOI: 10.1007/s00534-005-1000-5].
21. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226: 704-711; discussion 711-713 [PMID: 9409569 DOI: 10.1097/00000658-199712000-00 007].
22. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, Blumgart LH. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187: 620-625 [PMID: 9849736 DOI: 10.1016/S1072-7515(98)00240-3].
23. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg 2005; 242: 814-22, discussion 822-3 [PMID: 16327491 DOI: 10.1097/01. sla.0000189121.35617.d7].
24. Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, Ijichi M, Hasegawa K. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg 2001; 136: 922-928 [PMID: 11485528 DOI: 10.1001/archsurg.136.8.922].
25. Milsom J, Trencheva K, Monette S, Pavoor R, Shukla P, Ma J, Sonoda T. Evaluation of the safety, efficacy, and versatility of a new surgical energy device (THUNDERBEAT) in comparison with Harmonic ACE, LigaSure V, and EnSeal devices in a porcine model. J Laparoendosc Adv Surg Tech A 2012; 22: 378-386 [PMID: 22364404 DOI: 10.1089/lap.2011.0420].
26. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995; 130: 198-203 [PMID: 7848092 DOI: 10.1001/archsurg.1995.01430020088017].
27. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229: 322-330 [PMID: 10077043 DOI: 10.1097/00000658-199903000-00004].
28. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84: 1255-1259 [PMID: 9313707 DOI: 10.1002/bjs.1800840917].
29. Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective. J Hepatobiliary Pancreat Sci 2010; 17: 380-384 [PMID: 19865790 DOI: 10.1007/s00534-009-0229-9].
30. Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M. Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective. J Hepatobiliary Pancreat Sci 2010; 17: 385-388 [PMID: 19936599 DOI: 10.1007/s00534-009-0228-x].
31. Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med 1979; 90: 185-187 [PMID: 443650 DOI: 10.7326/0003-4819-90-2-185].
32. Chan SC, Lo CM, Chok KS, Sharr WW, Cheung TT, Tsang SH, Chan AC, Fan ST. Validation of graft and standard liver size predictions in right liver living donor liver transplantation. Hepatol Int 2011; 5: 913-917 [PMID: 21484120 DOI: 10.1007/s12072-011-9264-0].
33. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317-1321 [PMID: 7737637 DOI: 10.1002/hep.1840210515].
34. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003; 7: 325-330 [PMID: 12654556 DOI: 10.1016/S1091-255X(02)00370-0].
35. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512-519 [PMID: 10819059 DOI: 10.1067/msy.2000.105294].
36. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181 [PMID: 9362359 DOI: 10.1053/jhep.1997.v26.pm0009362359].
37. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188: 304-309 [PMID: 10065820 DOI: 10.1016/S1072-7515(9 8)00301-9].
38. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296 [PMID: 15647196 DOI: 10.1136/gut.2004.046524].
39. Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008; 25: 92-103 [PMID: 21326550 DOI: 10.1055/s-2008-1076679].
40. Lemasters JJ, Ji S, Thurman RG. Centrilobular injury following hypoxia in isolated, perfused rat liver. Science 1981; 213: 661-663 [PMID: 7256265 DOI: 10.1126/science.7256265].
41. Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000; 31: 255-260 [PMID: 10655244 DOI: 10.1002/hep.510310201].
42. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10: 803-808 [PMID: 3022488 DOI: 10.1007/BF01655244].
43. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008; 247: 49-57 [PMID: 18156923 DOI: 10.1097/SLA.0b013e31815f6e5b].
44. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-286 [PMID: 17315288 DOI: 10.1002/bjs.5719].
45. Palavecino M, Chun YS, Madoff DC, Zorzi D, Kishi Y, Kaseb AO, Curley SA, Abdalla EK, Vauthey JN. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery 2009; 145: 399-405 [PMID: 19303988 DOI: 10.1016/j.surg.2008.10.009].
46. Ribero D, Curley SA, Imamura H, Madoff DC, Nagorney DM, Ng KK, Donadon M, Vilgrain V, Torzilli G, Roh M, Vauthey JN. Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol 2008; 15: 986-992 [PMID: 18236112 DOI: 10.1245/s10434-007-9731-y].
47. Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much? Am J Surg 2005; 190: 87-97 [PMID: 15972178 DOI: 10.1016/j.amjsurg.2005.01.043].
48. Yanaga K, Honda H, Ikeda Y, Nishizaki AT, Yamamoto K, Sugimachi K. Significance of liver size in hepatic surgery. HPB Surg 1997; 10: 195-199; discussion 199-200 [PMID: 9184872 DOI: 10.1155/1997/34842].
49. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004; 135: 404-410 [PMID: 15041964 DOI: 10.1016/j.surg.2003.08.024].
50. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Kutsuna Y, Hayakawa N, Yamamoto H. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995; 117: 677-681 [PMID: 7778031 DOI: 10.1016/S0039-6060(95)80012-3].
51. Corrêa D, Schwartz L, Jarnagin WR, Tuorto S, DeMatteo R, D' Angelica M, Allen P, Brown K, Fong Y. Kinetics of liver volume changes in the first year after portal vein embolization. Arch Surg 2010; 145: 351-354; discussion 354-355 [PMID: 20404285 DOI: 10.1001/archsurg.2010.42].
52. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94: 1386-1394 [PMID: 17583900 DOI: 10.1002/bjs.5836].
53. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137: 675-680; discussion 680-681 [PMID: 12049538 DOI: 10.1001/archsurg.137.6.675].
54. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21: 434-439 [PMID: 7843717 DOI: 10.1002/hep.1840210226].
55. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999; 29: 1099-1105 [PMID: 10094953 DOI: 10.1002/hep.510290415].
56. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, Denys A, Sauvanet A. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237: 208-217 [PMID: 12560779 DOI: 10.1097/01.SLA.0000048447.16651.7B].
57. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004; 139: 766-774 [PMID: 15249411 DOI: 10.1001/archsurg.139.7.766].
58. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006; 93: 1091-1098 [PMID: 16779884 DOI: 10.1002/bjs.5341].
59. Seo DD, Lee HC, Jang MK, Min HJ, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ, Ko GY, Lee YJ, Lee SG. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization. Ann Surg Oncol 2007; 14: 3501-3509 [PMID: 17899289 DOI: 10.1245/s10434-007-9553-y].
60. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, Emile JF, Bismuth H. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232: 665-672 [PMID: 11066138 DOI: 10.1097/00000658-20 0011000-00008].
61. Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg 2000; 87: 879-882 [PMID: 10931022 DOI: 10.1046/j.1365-2168.2000.01438.x].
62. Wakabayashi H, Ishimura K, Okano K, Izuishi K, Karasawa Y, Goda F, Maeba T, Maeta H. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer 2001; 92: 2384-2390 [PMID: 11745294 DOI: 10.1002/1097-0142(2 0011101)].
63. Hayashi S, Baba Y, Ueno K, Nakajo M, Kubo F, Ueno S, Aikou T, Komokata T, Nakamura N, Sakata R. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol 2007; 48: 721-727 [PMID: 17729001 DOI: 10.1080/02841850701424514].
64. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 1996; 200: 559-563 [PMID: 8685357 DOI: 10.1148/radiology.200.2.8685357].
65. Gibo M, Unten S, Yogi A, Nakayama T, Ayukawa Y, Gibo S, Murayama S, Takara M, Shiraishi M. Percutaneous ipsilateral portal vein embolization using a modified four-lumen balloon catheter with fibrin glue: initial clinical experience. Radiat Med 2007; 25: 164-172 [PMID: 17514367 DOI: 10.1007/s11604-007-0120-z].
66. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 2005; 16: 215-225 [PMID: 15713922 DOI: 10.1097/01. RVI.0000147067.79223.85].
67. Shaw CM, Madoff DC. Acute Thrombosis of Left Portal Vein during Right Portal Vein Embolization Extended to Segment 4. Semin Intervent Radiol 2011; 28: 156-161 [PMID: 22654253 DOI: 10.1055/s-0031-1280655].
68. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987; 206: 30-39 [PMID: 3038039].
69. Chen MF, Hwang TL, Hung CF. Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg 1991; 213: 227-229 [PMID: 1998403 DOI: 10.1097/00000658-199103000-00008].
70. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, Furukawa K, Tanaka T, Tomoda F, Tanaka W. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993; 18: 79-85 [PMID: 8392029 DOI: 10.1002/hep.1840180114].
71. Nagino M, Nimura Y, Kamiya J, Kanai M, Hayakawa N, Yamamoto H. Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. AJR Am J Roentgenol 1998; 171: 1037-1039 [PMID: 9762992 DOI: 10.2214/ajr.171.4.9762992].
72. Elias D, De Baere T, Roche A, Mducreux J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86: 784-788 [PMID: 10383579 DOI: 10.1046/j.1365-2168.1999.01154.x].
73. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-272 [PMID: 11481611 DOI: 10.1053/jhep.2001.26513].
74. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 2011; 98: 825-834 [PMID: 21484773 DOI: 10.1002/bjs.7456].
75. Okabe H, Beppu T, Ishiko T, Masuda T, Hayashi H, Otao R, Hasita H, Okabe K, Sugiyama S, Baba H. Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival. J Surg Oncol 2011; 104: 641-646 [PMID: 21520093 DOI: 10.1002/jso.21928].
76. Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA, Wang LF. Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC. Asian Pac J Cancer Prev 2014; 15: 703-706 [PMID: 24568482 DOI: 10.7314/APJCP. 2014.1 5.2.703].
77. Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-520; discussion 520-522 [PMID: 8857855 DOI: 10.1097/00000658-199610000-00009].
78. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Twostage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777-785 [PMID: 11088072 DOI: 10.1097/00000658-200012000-00006].
79. Moussa ME, Bean AG, Habib NA. Repeated resection for malignant liver tumours. Ann R Coll Surg Engl 1995; 77: 364-368 [PMID: 7486764].
80. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009; 250: 440-448 [PMID: 19730175 DOI: 10.1097/SLA.0b013e3181b4539b].
81. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13: 1261-1268 [PMID: 16947009 DOI: 10.1245/s10434-006-9023-y].
82. Jamal MH, Hassanain M, Chaudhury P, Tran TT, Wong S, Yousef Y, Jozaghi Y, Salman A, Jabbour S, Simoneau E, Al-Abbad S, Al-Jiffry M, Arena G, Kavan P, Metrakos P. Staged hepatectomy for bilobar colorectal hepatic metastases. HPB (Oxford) 2012; 14: 782-789 [PMID: 23043668 DOI: 10.1111/j.1477-2574.2012.00543. x].
83. Tsai S, Marques HP, de Jong MC, Mira P, Ribeiro V, Choti MA, Schulick RD, Barroso E, Pawlik TM. Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford) 2010; 12: 262-269 [PMID: 20590896 DOI: 10.1111/j. 147 7-2574.2010.00161.x].
84. Togo S, Nagano Y, Masui H, Tanaka K, Miura Y, Morioka D, Endo I, Sekido H, Ike H, Shimada H. Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer. Hepatogastroenterology 2005; 52: 913-919 [PMID: 15966231].
85. Shimada H, Tanaka K, Masui H, Nagano Y, Matsuo K, Kijima M, Ichikawa Y, Ike H, Ooki S, Togo S. Results of surgical treatment for multiple ( > or =5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg 2004; 389: 114-121 [PMID: 14714186 DOI: 10.1007/s00423-003-0447-6].
86. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12: 297-303 [PMID: 18060468 DOI: 10.1007/s11605-007-0410-x].
87. Heinrich S, Jochum W, Graf R, Clavien PA. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice. J Hepatol 2006; 45: 35-42 [PMID: 16698111 DOI: 10.1016/j. jhep.2006.02.020].
88. Baumgart JLS, Lang H. A new method for induction of liver hypertrophy prior to right trisectionectomy: a report of three cases. HPB (Oxford) 2011; (13): 71-72 [DOI: 10.1111/j. 1477-2574.2011. 00308.x].
89. de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg 2012; 255: 415-417 [PMID: 22330039 DOI: 10.1097/SLA. 0b013e31824 8577d].
90. Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, Soubrane O, Schnitzbauer AA, Raptis D, Tschuor C, Petrowsky H, De Santibanes E, Clavien PA. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg 2014; 260: 829-836; discussion 836-838 [PMID: 25379854 DOI: 10.1097/SLA.0000000000000947].
91. Cavaness KM, Doyle MB, Lin Y, Maynard E, Chapman WC. Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis. J Gastrointest Surg 2013; 17: 207-212 [PMID: 22996934 DOI: 10.1007/s11605-012-2 029-9].
92. Vennarecci G, Laurenzi A, Santoro R, Colasanti M, Lepiane P, Ettorre GM. The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion. World J Surg 2014; 38: 1498-1503 [PMID: 24146197 DOI: 10.1007/s00268-013-2296-y].
93. Vennarecci G, Laurenzi A, Levi Sandri GB, Busi Rizzi E, Cristofaro M, Montalbano M, Piselli P, Andreoli A, D'Offizi G, Ettorre GM. The ALPPS procedure for hepatocellular carcinoma. Eur J Surg Oncol 2014; 40: 982-988 [PMID: 24767805 DOI: 10.1016/j.ejso.2014.04.002].
94. Levi Sandri GB, Lai Q, Rayar M, Sulpice L. ALPPS procedure for hepatocellular carcinoma with macrovascular thrombosis: a new opportunity? J Hepatol 2015; 62: 241-242 [PMID: 25200909 DOI: 10.1016/j.jhep.2014.08.048].
95. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012; 255: 405-414 [PMID: 22330038 DOI: 10.1097/SLA.0b013e31824856f5].
96. Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N, Baumgart J, Croome K, Hernandez-Alejandro R, Lang H, de Santibanes E, Clavien PA. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg 2014; 38: 1510-1519 [PMID: 24748319 DOI: 10.1007/s00268-014-2513-3].
97. Ielpo B, Quijano Y, Vicente E. Pearls and pitfalls on ALPPS procedure: new complications in a new technique. Updates Surg 2014; 66: 159-161 [PMID: 24584837 DOI: 10.1007/s13304-014-0 249-0].
98. Chan AC, Pang R, Poon RT. Simplifying the ALPPS procedure by the anterior approach. Ann Surg 2014; 260: e3 [PMID: 24866543 DOI: 10.1097/SLA.0000000000000736].
99. Nadalin S, Capobianco I, Li J, Girotti P, Königsrainer I, Königsrainer A. Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons Learned from 15 cases at a single centre. Z Gastroenterol 2014; 52: 35-42 [PMID: 24420797 DOI: 10.1055/s-0033-1356364].
100. Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulteam Esch J, Fürst G, Topp SA. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 2013; 100: 388-394 [PMID: 23124776 DOI: 10.1002/bjs.8955].
101. Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien PA. Systematic Review and Meta-Analysis of Feasibility, Safety, and Efficacy of a Novel Procedure: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Ann Surg Oncol 2015; 22: 3109-3120 [PMID: 25448799 DOI: 10.1245/s10434-014-4213-5].